Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Lauria

Showing results (41-50 of 219) with videos related to

Pageof 22
Sort By:
Haematologica|January 1, 1972
[Cytosine arabinoside alone and in association to other drugs in the therapy of acute myeloblastic leukemia]S Tura, P Ricci, M Baccarani, et al.
Minerva Cardioangiologica|January 31, 1998
[Hypokinetic arrhythmia, paradoxical chronotropic reaction and hypotension during dobutamine stress test]R Villani, M F Caccia, E Caprino, et al.
Giornale Di Clinica Medica|July 1, 1972
[Immunity, leukemias and lymphomas. VI. Immunological state of splenectomized patients with malignant granuloma, in relation to the histological type of the disease]G Danieli, P L Malini, M Montroni, et al.
Leukemia|May 1, 1994
In vitro susceptibility of acute leukemia cells to the cytotoxic activity of allogeneic and autologous lymphokine activated killer (LAK) effectors: correlation with the rate and duration of complete remission and with survivalF Lauria, D Raspadori, D Rondelli, et al.
Blood|May 15, 1994
CD7 expression does not affect the prognosis in acute myeloid leukemiaF Lauria, D Raspadori, M A Ventura, et al.
Annals of Hematology|November 1, 1993
Expression of adhesion molecules on acute leukemic blast cells and sensitivity to normal LAK activityD Raspadori, F Lauria, M A Ventura, et al.
Giornale Di Clinica Medica|May 1, 1972
[Immunity, leukemias and lymphomas. IV. Study of immunological reactivity in malignant granuloma in relationship to the histological type]G Danieli, P L Malini, M Montroni, et al.
Leukemia|November 1, 1994
Disease eradication in hairy cell leukemia patients treated with 2-chlorodeoxyadenosineA Carbone, G Reato, P F Di Celle, et al.
Leukemia & Lymphoma|March 18, 2000
Expression of the CD11c antigen in B-cell chronic lymphoproliferative disordersG Marotta, D Raspadori, C Sestigiani, et al.
Haematologica|December 13, 2000
Low-dose fludarabine and cyclophosphamide in elderly patients with B-cell chronic lymphocytic leukemia refractory to conventional therapyG Marotta, C Bigazzi, M Lenoci, et al.
Pageof 22

Showing results (41-50 of 219) with videos related to

Sort By:
Pageof 22
Haematologica|January 1, 1972
[Cytosine arabinoside alone and in association to other drugs in the therapy of acute myeloblastic leukemia]S Tura, P Ricci, M Baccarani, et al.
Minerva Cardioangiologica|January 31, 1998
[Hypokinetic arrhythmia, paradoxical chronotropic reaction and hypotension during dobutamine stress test]R Villani, M F Caccia, E Caprino, et al.
Giornale Di Clinica Medica|July 1, 1972
[Immunity, leukemias and lymphomas. VI. Immunological state of splenectomized patients with malignant granuloma, in relation to the histological type of the disease]G Danieli, P L Malini, M Montroni, et al.
Leukemia|May 1, 1994
In vitro susceptibility of acute leukemia cells to the cytotoxic activity of allogeneic and autologous lymphokine activated killer (LAK) effectors: correlation with the rate and duration of complete remission and with survivalF Lauria, D Raspadori, D Rondelli, et al.
Blood|May 15, 1994
CD7 expression does not affect the prognosis in acute myeloid leukemiaF Lauria, D Raspadori, M A Ventura, et al.
Annals of Hematology|November 1, 1993
Expression of adhesion molecules on acute leukemic blast cells and sensitivity to normal LAK activityD Raspadori, F Lauria, M A Ventura, et al.
Giornale Di Clinica Medica|May 1, 1972
[Immunity, leukemias and lymphomas. IV. Study of immunological reactivity in malignant granuloma in relationship to the histological type]G Danieli, P L Malini, M Montroni, et al.
Leukemia|November 1, 1994
Disease eradication in hairy cell leukemia patients treated with 2-chlorodeoxyadenosineA Carbone, G Reato, P F Di Celle, et al.
Leukemia & Lymphoma|March 18, 2000
Expression of the CD11c antigen in B-cell chronic lymphoproliferative disordersG Marotta, D Raspadori, C Sestigiani, et al.
Haematologica|December 13, 2000
Low-dose fludarabine and cyclophosphamide in elderly patients with B-cell chronic lymphocytic leukemia refractory to conventional therapyG Marotta, C Bigazzi, M Lenoci, et al.
Pageof 22